Jeff Yass’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.1M | Sell |
91,700
-40,300
| -31% | -$334K | ﹤0.01% | 7954 |
|
|
2026
Q1 | $1.11M | Buy |
132,000
+71,000
| +116% | +$746K | ﹤0.01% | 7614 |
|
|
2025
Q4 | $878K | Buy |
61,000
+38,900
| +176% | +$485K | ﹤0.01% | 7481 |
|
|
2025
Q3 | $213K | Sell |
22,100
-800
| -3% | -$7.08K | ﹤0.01% | 10859 |
|
|
2025
Q2 | $188K | Buy |
22,900
+5,700
| +33% | +$47.7K | ﹤0.01% | 11276 |
|
|
2025
Q1 | $123K | Buy |
+17,200
| New | +$128K | ﹤0.01% | 11388 |
|
|
2024
Q4 | – | Sell |
-37,400
| Closed | -$392K | – | 13043 |
|
|
2024
Q3 | $392K | Buy |
37,400
+3,900
| +12% | +$47.5K | ﹤0.01% | 9031 |
|
|
2024
Q2 | $392K | Buy |
+33,500
| New | +$521K | ﹤0.01% | 8848 |
|
|
2023
Q4 | – | Sell |
-11,900
| Closed | -$196K | – | 13159 |
|
|
2023
Q3 | $196K | Buy |
+11,900
| New | +$216K | ﹤0.01% | 10253 |
|
|
2022
Q4 | – | Sell |
-9,300
| Closed | -$246K | – | 13475 |
|
|
2022
Q3 | $246K | Buy |
+9,300
| New | +$276K | ﹤0.01% | 10306 |
|
|
2022
Q2 | – | Sell |
-32,000
| Closed | -$1.06M | – | 13781 |
|
|
2022
Q1 | $1.06M | Sell |
32,000
-9,300
| -23% | -$258K | ﹤0.01% | 6957 |
|
|
2021
Q4 | $1.35M | Sell |
41,300
-50,300
| -55% | -$1.71M | ﹤0.01% | 6476 |
|
|
2021
Q3 | $3.84M | Buy |
+91,600
| New | +$3.3M | ﹤0.01% | 4438 |
|
|
2021
Q2 | – | Sell |
-21,900
| Closed | -$747K | – | 13146 |
|
|
2021
Q1 | $747K | Sell |
21,900
-19,600
| -47% | -$836K | ﹤0.01% | 8485 |
|
|
2020
Q4 | $1.88M | Buy |
41,500
+22,400
| +117% | +$783K | ﹤0.01% | 5226 |
|
|
2020
Q3 | $526K | Sell |
19,100
-55,500
| -74% | -$1.81M | ﹤0.01% | 7553 |
|
|
2020
Q2 | $2.75M | Sell |
74,600
-42,000
| -36% | -$1.57M | ﹤0.01% | 3949 |
|
|
2020
Q1 | $3.78M | Sell |
116,600
-18,200
| -14% | -$758K | ﹤0.01% | 2947 |
|
|
2019
Q4 | $5.52M | Sell |
134,800
-15,400
| -10% | -$608K | ﹤0.01% | 2846 |
|
|
2019
Q3 | $5.35M | Buy |
150,200
+12,500
| +9% | +$506K | ﹤0.01% | 2637 |
|
|
2019
Q2 | $7.07M | Sell |
137,700
-103,200
| -43% | -$5.15M | ﹤0.01% | 2287 |
|
|
2019
Q1 | $13.8M | Buy |
240,900
+92,100
| +62% | +$4.56M | 0.01% | 1476 |
|
|
2018
Q4 | $6.24M | Buy |
148,800
+28,400
| +24% | +$1.67M | ﹤0.01% | 2052 |
|
|
2018
Q3 | $9.09M | Buy |
120,400
+2,100
| +2% | +$151K | ﹤0.01% | 2034 |
|
|
2018
Q2 | $8.49M | Buy |
118,300
+37,900
| +47% | +$1.81M | ﹤0.01% | 2109 |
|
|
2018
Q1 | $2.4M | Sell |
80,400
-25,700
| -24% | -$748K | ﹤0.01% | 3587 |
|
|
2017
Q4 | $3.53M | Buy |
106,100
+91,200
| +612% | +$2.75M | ﹤0.01% | 2986 |
|
|
2017
Q3 | $491K | Buy |
+14,900
| New | +$335K | ﹤0.01% | 6537 |
|
Other funds holding RGNX
RG
Jeff Yass's RGNX Position: Q2 2026 in Review
Jeff Yass increased its Regenxbio (RGNX) stake by 191% in Q2 2026, buying an estimated $1.44M and bringing the position to 264,912 shares worth $3.17M. The position accounts for ﹤0.01% of the portfolio, ranked #5511.
Jeff Yass first reported a position in RGNX in Q2 2016 and has held it in 34 quarters since. The position peaked at $4.02M in Q3 2019. 164 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.
- Jeff Yass held 264,912 shares of Regenxbio worth $3.17M as of Q2 2026.
- Jeff Yass bought 173,828 Regenxbio shares in Q2 2026, an estimated $1.44M.
- Regenxbio made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #5511 holding.
- Jeff Yass first reported a position in Regenxbio in Q2 2016 and has held it in 34 quarters since.
- Jeff Yass's Regenxbio position peaked at $4.02M in Q3 2019.
- 164 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.
Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.